Press Release
February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet...
Mountain View, California, January 31, 2022 ─ Crosscope Inc, a Silicon Valley-based leader of AI-enabled Digital Pathology Software, and BALCO Medical Centre, flagship unit of Vedanta Medical Research Foundation (VMRF), are joining hands for...
January 27, 2022 – The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is one of the 17 national awardees in the fifth call for projects in Hospital-University Research in Health (RHU5),...
Diagnosis of cancer and other diseases is a manual and challenging process for Pathologists in the field. IESA held a webinar focused on challenges faced and opportunities to use the latest developments in AI/ML for more efficient and accurate...
Artificial intelligence driven-gastrointestinal endoscopy can improve the diagnosis and treatment of digestive tract disorders BEIJING, Jan. 20, 2022 /PRNewswire/ -- Artificial intelligence (AI) has revolutionized the field of medical...
